Amgen - מכפיל EV/Sales AMGN

Complex cold chain transportation increases delivery costs, while patent protection and M&A deals retain customers despite pricing pressure from US law. This Enterprise Value to Revenue chart visualizes these cycles, where 7136.84 serves as the final level marker. The result secures Amgen Inc. (AMGN) the status of a biotech pioneer with high margins driven by unique protein developments.
AMGN (Amgen Inc.): פילוחים אנליטיים ודוחות לפי אינדיקטורים

This indicator determines the Enterprise Value of the entire business relative to annual sales, excluding the impact of capital structure. By analyzing the EV/Revenue multiple on the GURU.Markets platform, an investor assesses the market premium paid for every dollar of revenue. This metric's trend is sensitive to M&A transaction costs, which is critical for Amgen Inc. (AMGN) during aggressive acquisitions of biotech startups and the expansion of its biosimilars portfolio.